Physician profile
Samina Wahhab
NPI 1194795740
$6,479.06
in general payments reported to CMS, 2019-2025
16 companies · $1,807 in 2025
The $1,807 reported for 2025 was more than what 83% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,016 · 2020: $116 · 2021: $197 · 2022: $589 · 2023: $1,431 · 2024: $325 · 2025: $1,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362 · Honoraria: $1,200 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.76 |
| Honoraria | $1,200.00 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,186.14 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Merz North America, INC. | $1,401.85 | 2019-2020 | |
| Rti Surgical, INC | $1,299.93 | 2025 | |
| Allergan, INC. | $530.71 | 2019-2022 | |
| Mentor Worldwide LLC | $254.27 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $149.38 | 2024-2025 | Daxxify |
| Sientra, INC. | $141.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $115.20 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $106.69 | 2019-2025 | |
| Integra Lifesciences Corporation | $83.32 | 2022-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Abbvie INC. | $75.14 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $41.80 | 2022 | |
| Kerecis Limited | $31.24 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $25.57 | 2022 | |
| Galderma Laboratories, L.P. | $21.62 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $14.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samina Wahhab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.